172@29@16@18!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=1&is_responsive=1&sec=SWOT_DETAIL&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Ipca Laboratories Ltd.

BSE Live

Oct 29, 16:00
2350.00 15.05 (0.64%)
Volume
AVERAGE VOLUME
5-Day
66,479
10-Day
35,668
30-Day
22,246
5,820
  • Prev. Close

    2334.95

  • Open Price

    2336.00

  • Bid Price (Qty.)

    2320.00 (1)

  • Offer Price (Qty.)

    2349.80 (10)

NSE Live

Oct 29, 15:59
2349.30 11.80 (0.50%)
Volume
AVERAGE VOLUME
5-Day
726,823
10-Day
452,171
30-Day
312,668
359,506
  • Prev. Close

    2337.50

  • Open Price

    2300.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2349.30 (498)

Strengths (17)
  • Stock passes majority of CANSLIM Investment criteria
  • Company with high TTM EPS Growth
  • Strong QoQ EPS Growth in recent results
  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
  • Efficient in managing Assets to generate Profits - ROA improving since last 2 year
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Company with Low Debt
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Annual Net Profits improving for last 2 years
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge
  • FII / FPI or Institutions increasing their shareholding
  • Near 52 Week High
  • Companies with rising net profit margins - quarterly as well as TTM basis
  • Strong Momentum: Price above short, medium and long term moving averages
Weaknesses (3)
  • Companies with growing costs YoY for long term projects
  • Declining Net Cash Flow : Companies not able to generate net cash
  • Bearish Harami (Bearish Reversal)
Opportunities (5)
  • Brokers upgraded recommendation or target price in the past three months
  • Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
  • Negative to Positive growth in Sales and Profit with Strong Price momentum
  • Highest Recovery from 52 Week Low
  • RSI indicating price strength
Threats (0)
No data for this stock.
Powered by Trendlyne
Note :Financial Information is based on Consolidated numbers.